218 related articles for article (PubMed ID: 17185040)
1. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
Lombard C; Nagarkatti M; Nagarkatti P
Clin Immunol; 2007 Mar; 122(3):259-70. PubMed ID: 17185040
[TBL] [Abstract][Full Text] [Related]
2. A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator levels in mice via CB
Gu SM; Lee HJ; Lee TH; Song YJ; Kim YH; Han KM; Shin J; Park HK; Kim HS; Cha HJ; Yun J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1201-1209. PubMed ID: 28828742
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
4. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.
Henriquez JE; Crawford RB; Kaminski NE
Toxicol Appl Pharmacol; 2019 Apr; 369():82-89. PubMed ID: 30807757
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
Singh UP; Singh NP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 2012 Jan; 258(2):256-67. PubMed ID: 22119709
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy.
Liu Q; Wu Z; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Wang W; Chen S; Zhou N; Li Y; Shi B
Neurourol Urodyn; 2020 Jan; 39(1):158-169. PubMed ID: 31729056
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
Br J Cancer; 2009 Sep; 101(6):940-50. PubMed ID: 19690545
[TBL] [Abstract][Full Text] [Related]
10. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
Montecucco F; Burger F; Mach F; Steffens S
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1145-55. PubMed ID: 18178718
[TBL] [Abstract][Full Text] [Related]
11. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
[TBL] [Abstract][Full Text] [Related]
12. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
13. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
15. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
16. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
Ghosh S; Preet A; Groopman JE; Ganju RK
Mol Immunol; 2006 Jul; 43(14):2169-79. PubMed ID: 16503355
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis.
Xu H; Cheng CL; Chen M; Manivannan A; Cabay L; Pertwee RG; Coutts A; Forrester JV
J Leukoc Biol; 2007 Sep; 82(3):532-41. PubMed ID: 17537989
[TBL] [Abstract][Full Text] [Related]
19. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Fu W; Taylor BK
Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
